about
Early repolarization and myocardial scar predict poorest prognosis in patients with coronary artery disease.Diverse geometric changes related to dynamic left ventricular outflow tract obstruction without overt hypertrophic cardiomyopathy.Heart Rate Acceleration of a Subsidiary Pacemaker by β-Adrenergic Stimulation.Does additional linear ablation after circumferential pulmonary vein isolation improve clinical outcome in patients with paroxysmal atrial fibrillation? Prospective randomised study.Combined ECG, Echocardiographic, and Biomarker Criteria for Diagnosing Acute Myocardial Infarction in Out-of-Hospital Cardiac Arrest PatientsLeft Ventricular Filling Pressure as Assessed by the E/e' Ratio Is a Determinant of Atrial Fibrillation Recurrence after Cardioversion.Prognostic Value of Elevated Homocysteine Levels in Korean Patients with Coronary Artery Disease: A Propensity Score Matched Analysis.Preventive effect of pretreatment with intravenous nicorandil on contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography (PRINCIPLE Study).Usefulness of metabolic syndrome score in the prediction of angiographic coronary artery disease severity according to the presence of diabetes mellitus: relation with inflammatory markers and adipokines.High Prevalence and Clinical Implication of Myocardial Bridging in Patients with Early Repolarization.Left atrial function assessed by Doppler echocardiography rather than left atrial volume predicts recurrence in patients with paroxysmal atrial fibrillation.Right atrial anatomical remodeling affects early outcomes of nonvalvular atrial fibrillation after radiofrequency ablation.Left ventricular hypertrophy determines the severity of diastolic dysfunction in patients with nonvalvular atrial fibrillation and preserved left ventricular systolic function.Impact of atrial fibrillation on the clinical course of apical hypertrophic cardiomyopathy.Bleeding risk and major adverse events in patients with cancer on oral anticoagulation therapy.Left Atrial Volume Index Predicts Recurrence of Stroke in Patients with Nonsustained Atrial Tachycardia.Gender Difference in the Long-Term Clinical Implications of New-Onset Atrial Fibrillation after Coronary Artery Bypass Grafting.Optimal pharmacologic approach to patients with hypertriglyceridemia and low high-density lipoprotein-cholesterol: randomized comparison of fenofibrate 160 mg and niacin 1500 mg.Effects of atorvastatin 20 mg, rosuvastatin 10 mg, and atorvastatin/ezetimibe 5 mg/5 mg on lipoproteins and glucose metabolism.Local increase in microparticles from the aspirate of culprit coronary arteries in patients with ST-segment elevation myocardial infarction.Three-Dimensional Echocardiographic Evaluation of Mitral Apparatus during Preload Manipulation in Patients with Hypertrophic Cardiomyopathy.Comparison of effects of drug-eluting stents versus bare metal stents on plasma C-reactive protein levels.Outcomes of cardiac involvement in patients with late-stage Duchenne muscular dystrophy under management in the pulmonary rehabilitation center of a tertiary referral hospital.The safety and efficacy of vitamin K antagonist in patients with atrial fibrillation and liver cirrhosis.Fate of preoperative atrial fibrillation after correction of atrial septal defect.The role of critical shear stress on acute coronary syndrome.Does a carbon ion-implanted surface reduce the restenosis rate of coronary stents?Effect of a single bolus injection of low-dose hydrocortisone for prevention of atrial fibrillation recurrence after radiofrequency catheter ablation.Predictors of stent fracture in patients treated with closed-cell design stents: sirolimus-eluting stent and its bare-metal counterpart, the BX velocity stent.Percutaneous treatment of deep vein thrombosis in May-Thurner syndrome.Comparison of arterial stiffness indices measured by the Colins and SphygmoCor systemsImportance of tachycardia cycle length for differentiating typical atrial flutter from scar-related in adult congenital heart diseaseThe type of sinus node dysfunction might predict the severity of atrial remodeling and clinical outcome after catheter ablation of atrial fibrillationNew-onset atrial fibrillation predicts long-term newly developed atrial fibrillation after coronary artery bypass graftSocial Inequalities of Oral Anticoagulation after the Introduction of Non-Vitamin K Antagonists in Patients with Atrial FibrillationPermanent Pacemaker Implantations after Catheter Ablation in Patients with Atrial Fibrillation Associated with Underlying Sinus Node Dysfunction
P50
Q33822565-0CF9A35D-752D-4A42-884F-25B38572D2FCQ33864319-97D290A6-C9A9-4FA7-8912-4A8C74B1F201Q35622092-35E8736A-8464-49EF-8B40-0FCFFF0BDA8FQ35773242-6301AEC9-97CB-48F1-AF03-B03B3A83E2F7Q35778260-CD1F7E2B-E4BC-40F0-93D5-9BF168B4A4C2Q36418761-1719261E-AF03-4F49-BD47-B0DF4E41C8D9Q36723469-19D79C0D-8149-4D34-A5D1-56502A16F60DQ36872875-E42707B6-5F98-41EF-BE50-5F8BCA7699C8Q37363488-95E68B35-FDB8-46AA-AE66-433B2850E44AQ37438409-5B108489-0B27-4C9E-9D6D-B4A0BC72066EQ38452374-E10393CB-CC01-4F20-8F30-5AA07635E0B6Q38465969-5B6A0084-87FE-4D98-8D0E-A6122836F6E7Q38479543-0ABAC69B-1C12-4A7D-B82F-3BD166A5FE73Q38827720-92AD61A6-7708-49E3-A33C-B3FA3259256BQ41147883-C38C5579-F512-49BF-B403-6D36FF5315F7Q41483474-EC1D6982-8C26-48A5-9C4A-39CD89F5E4C5Q42646998-8C1311B9-C354-41C4-AAA3-EFA6B04234F0Q42882918-D31422B7-7CE1-40EF-8971-71E95167E218Q43165990-71826930-A0FA-4C4D-93A6-6796BDFDDC42Q43531891-33FD2A7E-702C-4123-9F21-7943F140ABF8Q46450983-80BF5E7B-000C-4BB5-9E42-2AE2EFFF048FQ46794555-9BEBA721-D4A9-45B3-8D7C-01390DBF9EE4Q47896681-91AB7969-E155-435A-9111-42394CD56285Q48428180-193F3C1B-CF30-4257-AFAE-903C4D84839CQ49063993-07AC45F9-CDD5-47B4-9797-2EC87C8C2B78Q50192852-63D005A5-5F9D-46DD-9679-0ED49394C265Q51401456-442FC0FB-2C9F-4633-BE7E-7201297E07E3Q53143592-31DCC7B6-389D-4D52-8AE8-3670FE468D81Q53450024-3A7B9E94-0335-4BE3-BDF3-149ECDA9444BQ53603090-02474E47-5EDA-4F25-9725-435F5B9F16B2Q58202844-307F3293-96C4-4A03-8FFF-DE101E69532FQ84809773-CCD2A4CC-0249-4366-A2BB-2F0018ECC261Q87263211-FAF86706-D337-48A4-95FF-05FA740BE91AQ87491193-0677CF85-A49F-4A21-BC4C-D54C7668D4BDQ89888722-B541BE2E-03D3-42D1-9876-D96BE51B827CQ92792571-0B43E6D4-6969-4477-A9C2-14219E2C90C6
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Jong-Youn Kim
@en
Jong-Youn Kim
@nl
type
label
Jong-Youn Kim
@en
Jong-Youn Kim
@nl
prefLabel
Jong-Youn Kim
@en
Jong-Youn Kim
@nl
P31
P496
0000-0001-7040-8771